Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...

Heart disease is killing more women in Pakistan than previously understood, with female patients experiencing higher mortality rates, more severe symptoms and delayed diagnoses compared to men, ...

Heart failure, a leading cause of death in the US, can be triggered by cardiac amyloidosis, a condition often misdiagnosed as ...

The FDA expanded the indication for finerenone (Kerendia) in heart failure (HF), drug manufacturer Bayer announced.

Micah Clayborne was diagnosed with Danon disease, a rare condition, after complaining of chest pains. He needed a heart ...

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

Heart failure, a condition where the heart doesn't pump blood efficiently, manifests through symptoms like shortness of ...

Wearables and telehealth are teaming up to transform chronic care. This connected model offers real-time data for proactive, ...

The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...

Piedmont has expanded access to outpatient heart failure management with a new heart failure clinic at Piedmont Newton ...

Discover how MemorialCare's Women's Heart Center at Long Beach is tackling the leading killer of women, heart disease, ...

A common habit may be increasing your risk of heart disease, heart failure and stroke, a study suggests. Researchers found ...